MEXICO
Pharmaceutical
Project
Captiva Verde Land was the very first mover in the Mexico pharmaceutical markets to manufacture, distribute and sell psilocybin and other psychoactive medicines under our comprehensive Mexican license that includes over 300 other narcotics and psychoactive substances.
Led by Mexican health and business leaders, successful operating business executives, and capital market experts, management has a unique track record of delivering exceptional returns to shareholders.
Captiva Verde is focused on the immediate commercialization of the sales of micro-doses of psilocybin under our license in Mexico, in addition to other psychoactive medicines that enhance and improve the quality of life.
Captiva’s sole mission is to provide all of Mexico with the highest quality medical products, including cannabis products, that are sourced from the best suppliers that have the highest proven efficacy all at the lowest possible prices to the Mexican consumer.
Captiva has one licensed facility in Mexico for distribution and the construction of our lab and manufacturing facilities in Baja California has already begun.
Psilocybin is hallucinogen that works by activating serotonin receptors, most often in the prefrontal cortex. Psilocybin is consumed for their hallucinogenic effects and it belongs to a group of drugs known as psychedelics, because of the changes experienced to perception, mood and thought. Psilocybin is a proven drug with various health benefits and has low level of toxicity and dependence.
